Kuby Immunology 6/e
Download
Report
Transcript Kuby Immunology 6/e
Chapter 19
Cancer and the Immune System
Dr. Capers
Cancer
Altered self cells
Unregulated mitosis
○ Produces tumor (neoplasm)
Benign – does not invade healthy tissue
Malignant – grows and becomes invasive
- Exhibit metastasis
Malignant cancers are classified according
to embryonic origin of tissue
○ Carcinomas
Endodermal or ectodermal
Skin or epithelial lining of internal organs and glands
Colon, breast, prostate, lung
○ Leukemias and lymphomas
Tumors of hematopoietic cells of bone marrow
Leukemias proliferate as single cells
Lymphomas grow as tumor masses
○ Sarcomas
Mesodermal connective tissue
Bone, fat, cartilage
Malignant transformation
Ability for cell to form cancer
○ Decreased requirements for growth factors
○ No longer anchorage dependent
What can cause this?
○ Various chemical agents
○ Radiation
○ viruses
Genes that code for
proteins involved in
cell proliferation are
called
proto-oncogenes;
mutations in these
genes can lead to
increased
proliferation
Chromosomal translocations
Can lead to movement of proto-
oncogenes
This can lead to increased
transcription and translation of
the protein
Induction of cancer is a multi-step
process
Multiple and subsequent mutations
Tumors of Immune System
Leukemias or Lymphomas
Lymphomas
○ Solid tumors in lymphoid tissue
○ Include Hodgkin’s and non-Hodgkin’s lymphomas
Leukemias
○ Proliferate as single cells
○ Lymphoid or myeloid lineage
○ Acute – appear and progress rapidly, tend to rise
in immature cells
○ Chronic – less aggressive and slow, tend to rise in
mature cells, tend to be in adults
Tumor Antigens
Tumor-specific transplantation antigens
(TSTAs)
○ Unique to tumor cells
○ May arise due to mutation
○ Are presented on Class I MHC
Tumor-associated transplantation antigens
(TATAs)
○ Proteins expressed on normal cells
Inappropriate expression of embryonic gene
Overexpression of normal protein
Some antigens are tumor specific
Oncofetal antigens
Found on normal fetal cells
Only meant to be expressed during embryological
development
Suppressed after development of fetus is completed
If expressed later in adult, could induce
immune response
Immune system may see these as nonself
Can lead to cancer
~90% of colorectal cancer have CEA
(carcinoembryonic antigen)
Tumor Invasion of Immune System
Anti-tumor antibodies
○ Might actually block sites for CTL to bind
Tumor cells might express less Class I
MHC
○ This prevents CTL-mediated death
Tumor cells may provide poor
costimulatory signals
Cancer Immunotherapy
Manipulation of costimulatory signals
Enhancement of antigen-presenting cells
Cytokine therapy
○ Interferons
○ Tumor necrosis factors
Monoclonal Abs may be used for some
tumors
○ Immunotoxins may be linked to kill specific tumor
cell, still being researched
Radioactive isotope, drugs